Karolinska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2009

  1. A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

    Blood, Vol. 114, Núm. 6, pp. 1166-1173

2001

  1. BIOMED-I concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

    Leukemia, Vol. 15, Núm. 8, pp. 1185-1192

1999

  1. Immunophenotypical detection of minimal residual disease in acute leukemia

    Critical Reviews in Oncology/Hematology, Vol. 32, Núm. 3, pp. 175-185